- Multiple Sclerosis Journal
Multiple Sclerosis Journal Abbreviated title (ISO) Mult. Scler. J. Discipline Medical Sciences Edited by Alan J Thompson Publication details Publisher SAGE Publications Publication history 1995-present Frequency Monthly Impact factor
4.230 Indexing ISSN 1352-4585 (print)
LCCN 96039038 CODEN MUSCFZ OCLC number 39932110 Links
Multiple Sclerosis Journal is a peer-reviewed academic journal that publishes papers in the field of Clinical Neurology. The journal's editor is Alan J. Thompson ([University College London]]). It has been in publication since 1995 and is currently published by SAGE Publications.
Multiple Sclerosis Journal is an international, monthly, peer reviewed journal. It focuses on the causes and pathology of demyelinating and inflammatory diseases of the central nervous system, and on the application of such studies to scientifically based therapy. Topics covered include: Clinical neurology, Myelin chemistry, Neuroimaging, Pathobiology of the blood/brain barrierm, Glial pathobiology/myelin repair, Pathology, Epidemiology, Therapeutics, Genetics, Immunology, Psychology, Rehabilitation. The journal is a member of the Committee on Publication Ethics (COPE)
Multiple Sclerosis Journal publishes reviews, research papers and short reports, as well as monthly Topical Reviews and a series of debates: Controversies in Multiple Sclerosis. Multiple Sclerosis Journal offers optional funded open access.
Abstracting and indexing
Multiple Sclerosis Journal is abstracted and indexed in a wide variety of databases, including
- Biological Abstracts
- Current Contents
- Excerpta Medica
- Elsevier BIOBASE
- Current Awareness in Biological Sciences
- Excerpta Medica
- Index Medicus
- Neuroscience Citation Index
According to the Journal Citation Reports, its 2010 impact factor is 4.230, ranking it 29 out of 185 journals in the category ‘Clinical Neurology’.
History of the Multiple Sclerosis Journal
The Multiple Sclerosis Journal was first published by Sage in 1995, under the founding editorship of Prof. (now Dame) Ingrid Allen, who is currently Professor Emeritus of Neuropathology at Queen’s University, Belfast. Three issues appeared in 1995, five in 1996, and from 1997 six issues appeared each year until 2006. In 2007 there were nine issues and in 2009, the current monthly publication was established.
Prof. Donald Silverberg subsequently assumed the editorship of the journal, and in 1999 he asked Prof. Alan Thompson, current Director of the Institute of Neurology, University College London, UK, to join the journal as European Editor. Donald Silverberg retired in 2006 and Alan Thompson became Editor in Chief, recruiting Profs. Jack Antel and William Carroll – with special responsibility for the Americas and the Asia-Pacific regions, respectively.
Multiple Sclerosis Journal serves the entire community from research scientists to those involved in the clinical and rehabilitation aspects of the disease.
The subject has grown out of all recognition during the journal’s seventeen years of publication – from a time when MS was assumed to be an intractable condition, to one where it is now seen as treatable. In her editorial in the first issue, Ingrid Allen spoke of MRI as an emerging technology, and now it is a key tool in all branches of medical research and diagnosis, including MS.
Autumn 2011 saw the launch of two new initiatives in the Multiple Sclerosis Journal. Monthly Topical Reviews highlight areas of current excitement that benefit from up to date summaries. Controversies in Multiple Sclerosis take the form of a proposal, a rebuttal and a summary, organised around a topic of current debate.
- ^ "Journals Ranked by Impact: Clinical Neurology". 2010 Journal Citation Reports (Sciences ed.). Thomson Reuters. 2011.
- SAGE academic journals
- English-language journals
Wikimedia Foundation. 2010.